Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia

Por Bibault, Jean-Emmanuel, Figeac, Martin, Hélevaut, Nathalie, Rodriguez, Céline, Quief, Sabine, Sebda, Shéhérazade, Renneville, Aline, Nibourel, Olivier, Rousselot, Philippe, Gruson, Bérengère, Dombret, Hervé, Castaigne, Sylvie, Preudhomme, Claude
Publicado no Oncotarget (2015)

Beneficial Effect of a Selective Adenosine A(2A) Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease

Por Faivre, Emilie, Coelho, Joana E., Zornbach, Katja, Malik, Enas, Baqi, Younis, Schneider, Marion, Cellai, Lucrezia, Carvalho, Kevin, Sebda, Shéhérazade, Figeac, Martin, Eddarkaoui, Sabiha, Caillierez, Raphaëlle, Chern, Yijuang, Heneka, Michael, Sergeant, Nicolas, Müller, Christa E., Halle, Annett, Buée, Luc, Lopes, Luisa V., Blum, David
Publicado no Front Mol Neurosci (2018)

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association

Por Debarri, Houria, Lebon, Delphine, Roumier, Christophe, Cheok, Meyling, Marceau-Renaut, Alice, Nibourel, Olivier, Geffroy, Sandrine, Helevaut, Nathalie, Rousselot, Philippe, Gruson, Bérengère, Gardin, Claude, Chretien, Marie-Lorraine, Sebda, Shéhérazade, Figeac, Martin, Berthon, Céline, Quesnel, Bruno, Boissel, Nicolas, Castaigne, Sylvie, Dombret, Hervé, Renneville, Aline, Preudhomme, Claude
Publicado no Oncotarget (2015)